CVS Health Corporation (LON:0HRS)
78.49
+0.62 (0.80%)
At close: Dec 19, 2025
CVS Health Employees
As of December 31, 2024, CVS Health had 300,000 total employees, including 219,000 full-time and 81,000 part-time employees. The number of employees did not change compared to the previous year.
Employees
300,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
1.12M GBP
Profits / Employee
1.34K GBP
Market Cap
73.77B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 300,000 | 0 | - |
| Dec 31, 2023 | 300,000 | 0 | - |
| Dec 31, 2022 | 300,000 | 0 | - |
| Dec 31, 2021 | 300,000 | 0 | - |
| Dec 31, 2020 | 300,000 | 10,000 | 3.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| Convatec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| Genus | 3,190 |
| HUTCHMED (China) | 1,811 |
CVS Health News
- 5 days ago - CVS Stock Gains From Offering MMR Vaccine to South Carolina Residents - Nasdaq
- 5 days ago - Gabelli Pet Parents' Fund Q3 2025 Contributors And Detractors - Seeking Alpha
- 5 days ago - Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields - Benzinga
- 6 days ago - SA Asks: Are health insurance stocks a buy, sell, or hold right now? - Seeking Alpha
- 6 days ago - CVS Health (CVS) Adjusts 2026 Revenue Outlook - GuruFocus
- 6 days ago - Notable healthcare headlines for the week: CVS, Eli Lilly and Novartis in focus - Seeking Alpha
- 6 days ago - Top Wall Street analysts are upbeat on these 3 dividend stocks for enhanced returns - CNBC
- 8 days ago - Why CVS Health (CVS) is a Top Momentum Stock for the Long-Term - Nasdaq